These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


269 related items for PubMed ID: 16881431

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Vancomycin Dosing Regimen by Monte Carlo Simulation in Patients on Intermittent High-Efficiency Hemodialysis (HEHD).
    Rungprai D, Jaruratanasirikul S, Wongpoowarak W, Pattharachayakul S, Wanakamanee U, Dandecha P, Jitsurong A.
    J Med Assoc Thai; 2015 Jun; 98(6):606-15. PubMed ID: 26219166
    [Abstract] [Full Text] [Related]

  • 24. Subtherapeutic serum vancomycin concentrations during on-line hemodiafiltration.
    Sombolos KI, Fragidis SK, Bamichas GI, Hatsiou VN, Rizos AK, Natse TA, Fytili CI.
    ASAIO J; 2011 Jun; 57(6):507-10. PubMed ID: 21946313
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of temsirolimus pharmacokinetics in patients with renal cell carcinoma not receiving dialysis and those receiving hemodialysis: a case series.
    Lunardi G, Armirotti A, Nicodemo M, Cavallini L, Damonte G, Vannozzi MO, Venturini M.
    Clin Ther; 2009 Aug; 31(8):1812-9. PubMed ID: 19808140
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Augmented renal clearance in septic patients and implications for vancomycin optimisation.
    Baptista JP, Sousa E, Martins PJ, Pimentel JM.
    Int J Antimicrob Agents; 2012 May; 39(5):420-3. PubMed ID: 22386742
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low-Efficiency Dialysis.
    Rider TR, Silinskie KM, Hite MS, Bress J.
    Pharmacotherapy; 2020 Oct; 40(10):1036-1041. PubMed ID: 32866291
    [Abstract] [Full Text] [Related]

  • 32. Can population pharmacokinetic modelling guide vancomycin dosing during continuous renal replacement therapy in critically ill patients?
    Udy AA, Covajes C, Taccone FS, Jacobs F, Vincent JL, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2013 Jun; 41(6):564-8. PubMed ID: 23473944
    [Abstract] [Full Text] [Related]

  • 33. Influence of cellulose triacetate hemodialyzers on vancomycin pharmacokinetics.
    Welage LS, Mason NA, Hoffman EJ, Odeh RM, Dombrouski J, Patel JA, Swartz RD.
    J Am Soc Nephrol; 1995 Oct; 6(4):1284-90. PubMed ID: 8589298
    [Abstract] [Full Text] [Related]

  • 34. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Boereboom FT, Ververs FF, Blankestijn PJ, Savelkoul TJ, van Dijk A.
    Intensive Care Med; 1999 Oct; 25(10):1100-4. PubMed ID: 10551965
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Vancomycin removal during low-flux and high-flux extended daily hemodialysis in critically ill septic patients.
    Petejova N, Martinek A, Zahalkova J, Duricova J, Brozmanova H, Urbanek K, Grundmann M, Kacirova I.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):342-7. PubMed ID: 22660225
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L, Andresen M, Downey P, Gai MN, Regueira T, Bórquez T, Lipman J, Roberts JA.
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.